A 67-year-old man with a history of type 2 diabetes, diabetic peripheral neuropathy, and hypertension presents to the emergency department with a skin ulceration on the bottom of his great toe ...
A leg is amputated every 30 seconds globally, and up to 85% of amputations are due to complications of diabetic foot ulcers (DFUs). This global tragedy calls for strategic and preventative solutions—a ...
LifeNet Health, a global leader in regenerative medicine, has received the Best Randomized Controlled Trial Award at the 2026 CAMPs Awards for its Matrion® diabetic foot ulcer study. In this ...
(MENAFN- GetNews) The Key Diabetic Foot Ulcers Companies in the market include - Amniox (TissueTech), Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion ...
Shares of Organogenesis Holdings were higher after the company said its product for non-healing diabetic foot ulcers met its primary endpoint in a recent trial. The stock rose 30%, to $2.91, in ...
FibroBiologics Inc. FBLG on Tuesday said it completed manufacturing of the first batch of FibroBiologics' proprietary CYWC628 drug product that will support upcoming first-in-human clinical trials.
FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...
Embecta’s implied fair value has been reset from US$16.67 to US$15.00, giving you a fresh reference point for where analysts now see the stock. That reduction lines up with recent commentary that ...
Aroa Biosurgery’s Symphony trial has met its primary endpoint in diabetic foot ulcers, with preliminary findings indicating improved outcomes versus ... Read More The post Aroa’s Symphony hits the ...
Know the early warning signs of piles, hernia, diabetic foot and varicose veins. Timely care can prevent serious complications and improve long-term health outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results